Gemina's Recent Investment into RAPIvD Sees Immediate Progress
VANCOUVER, BC / ACCESSWIRE / December 13, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that RAPIvD Limited ("RAPIvD") has met an important regulatory milestone.On December 7, 2022, Gemina …
Weiterlesen »